Tylor Megill Undergoes Tommy John Surgery

Mets right-hander Tylor Megill underwent Tommy John surgery yesterday. Anthony DiComo of MLB.com was among those to relay the news. Megill will miss the remainder of this year and likely all of 2026 as well. It was reported last week that he had been recommended for the procedure.

The news doesn’t come as a shock. He has been on the injured list since June due to right elbow inflammation. He had begun a rehab assignment in August but was shut down in early September due to renewed soreness. As mentioned, he was recommended for surgery a few days ago, though he was still considering other options. It seems he couldn’t find a viable non-surgical alternative and decided to go under the knife.

The 30-year-old has generally put up decent numbers for the Mets over the years. In total, he has thrown 409 2/3 innings over five seasons, allowing 4.46 earned runs per nine innings. He has struck out 24.3% of batters faced, given out walks at a 9.3% clip and kept the ball on the ground at a 42% pace.

His volume of major league work has been capped by a few factors. The Mets have often had him just outside the top five of their depth chart, meaning he has been shuttled to Triple-A and back a number of times, depending on the overall health of the staff. He has also had a few injury absences of his own, including shoulder strains in both 2022 and 2024. He has only once surpassed 90 innings in a big league season and has never hit 130.

This year was Megill’s first arbitration season and he is making a salary of $1.975MM. He can be controlled for two more seasons via arbitration. He’ll be in line for a raise for next year, though he’ll be a bit limited by the fact that he only made 14 starts this season. The Mets could tender him a contract, perhaps bumping him into the $3MM range, speculatively speaking. They wouldn’t get anything in return for that investment in 2026, as the odds of him returning late in 2026 would be very low, but they could then keep him around for 2027 at about the same price.

They will have a few weeks to decide if they think Megill’s 2027 worth that kind of multi-year investment. In addition to the money, they will have to think about the roster ramifications. There’s no IL between the World Series and the start of spring training. If they want to keep paying Megill over the next year-plus with the plan of having him be a part of the 2027 club, he would have to take up a roster spot through this winter. He could then be put back on the 60-day IL during the 2026 season, though he would have to retake a roster spot again in the 2026-27 offseason.

Regardless of that decision, he won’t be part of the club’s rotation plans for the next year. The Mets will go into this offseason with their potential 2026 starting group including David Peterson, Clay Holmes, Nolan McLean, Jonah Tong, Brandon Sproat, Kodai Senga, Sean Manaea and Christian Scott.

Photo courtesy of Gary A. Vasquez, Imagn Images